Stock listing
NASDAQ:NRIX Nurix Therapeutics, Inc. Stock
Home listing (NASDAQ) of Nurix Therapeutics, Inc.
Follow Nurix Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:NRIX
$26.80 USD -0.32 (-1.2%)
Close on Oct 30, 2026
- Day range
- $25.97 – $26.92 USDOct 30, 2026
- Volume
- 2.31M sharesOct 30, 2026
- Market cap
- $2.93B USDAt the close on Oct 30, 2026 · price × 109.2M shares outstanding
- 52-week range
- $11.67 – $28.23 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $42.49M USDMedian day 1.37M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NRIX · Home | $26.80 USD | -0.32 (-1.2%) | 2,311,432 | $26.90 | $26.92 | $25.97 | $27.12 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:NRIX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $26.80 | -0.32 | -1.2% | $26.90 | $26.92 | $25.97 | 2,311,432 | |
| $27.12 | -0.14 | -0.5% | $27.46 | $27.99 | $26.69 | 2,258,885 | |
| $27.26 | +0.56 | +2.1% | $26.26 | $27.28 | $25.45 | 1,957,249 | |
| $26.70 | +1.15 | +4.5% | $25.52 | $27.05 | $25.13 | 2,562,853 | |
| $25.55 | +0.21 | +0.8% | $25.35 | $25.82 | $25.04 | 2,336,855 | |
| $25.34 | -0.17 | -0.7% | $25.22 | $25.49 | $24.78 | 1,910,400 | |
| $25.51 | -0.51 | -2.0% | $25.86 | $26.23 | $25.18 | 1,933,900 | |
| $26.02 | -0.08 | -0.3% | $26.00 | $26.31 | $25.80 | 2,928,300 | |
| $26.10 | +1.17 | +4.7% | $24.92 | $26.34 | $24.71 | 3,979,800 | |
| $24.93 | +0.51 | +2.1% | $24.57 | $25.29 | $24.38 | 3,064,100 | |
| $24.42 | -0.53 | -2.1% | $24.89 | $25.36 | $24.27 | 4,318,300 | |
| $24.95 | +1.28 | +5.4% | $23.67 | $25.14 | $23.61 | 3,753,400 | |
| $23.67 | +1.54 | +7.0% | $22.01 | $24.01 | $21.40 | 3,820,700 | |
| $22.13 | -0.03 | -0.1% | $22.16 | $23.24 | $21.75 | 4,680,800 | |
| $22.16 | -0.19 | -0.9% | $22.27 | $22.58 | $22.03 | 2,850,900 | |
| $22.35 | +0.14 | +0.6% | $22.04 | $23.23 | $21.23 | 1,525,100 | |
| $22.21 | -0.52 | -2.3% | $22.49 | $22.60 | $21.55 | 2,344,900 | |
| $22.73 | +0.13 | +0.6% | $22.43 | $23.10 | $22.18 | 1,631,800 | |
| $22.60 | -0.28 | -1.2% | $23.06 | $23.06 | $22.10 | 1,154,200 | |
| $22.88 | -0.11 | -0.5% | $22.81 | $23.31 | $22.43 | 1,006,500 | |
| $22.99 | -0.35 | -1.5% | $23.72 | $23.75 | $22.85 | 815,500 | |
| $23.34 | -0.37 | -1.6% | $23.60 | $23.99 | $23.21 | 1,334,900 | |
| $23.71 | +0.035 | +0.1% | $23.85 | $23.94 | $23.34 | 2,010,700 | |
| $23.68 | +0.005 | 0.0% | $23.57 | $23.91 | $23.25 | 2,275,400 | |
| $23.67 | +0.66 | +2.9% | $22.86 | $23.69 | $22.41 | 2,007,900 | |
| $23.01 | -0.64 | -2.7% | $23.78 | $23.81 | $22.98 | 1,540,100 | |
| $23.65 | -0.23 | -1.0% | $23.76 | $23.93 | $23.02 | 2,023,100 | |
| $23.88 | -1.79 | -7.0% | $25.49 | $25.56 | $23.85 | 1,364,000 | |
| $25.67 | +0.26 | +1.0% | $25.32 | $25.96 | $25.23 | 1,509,600 | |
| $25.41 | -0.03 | -0.1% | $25.73 | $25.93 | $25.06 | 1,516,700 | |
| $25.44 | -0.06 | -0.2% | $25.32 | $25.80 | $25.01 | 2,839,500 | |
| $25.50 | +0.35 | +1.4% | $25.79 | $26.35 | $25.37 | 1,511,900 | |
| $25.15 | +0.32 | +1.3% | $24.87 | $25.29 | $24.68 | 1,236,400 | |
| $24.83 | -0.69 | -2.7% | $25.47 | $25.50 | $24.27 | 1,251,000 | |
| $25.52 | +0.42 | +1.7% | $25.01 | $26.14 | $24.95 | 1,330,800 | |
| $25.10 | -0.71 | -2.8% | $26.31 | $26.65 | $25.00 | 1,321,700 | |
| $25.81 | -0.45 | -1.7% | $25.89 | $25.99 | $25.50 | 1,029,500 | |
| $26.26 | +0.13 | +0.5% | $26.46 | $26.70 | $25.91 | 1,027,400 | |
| $26.13 | -0.01 | 0.0% | $25.42 | $26.42 | $25.36 | 1,287,900 | |
| $26.14 | +0.82 | +3.2% | $25.19 | $26.22 | $24.97 | 1,232,100 | |
| $25.32 | -0.50 | -1.9% | $25.82 | $26.16 | $24.95 | 1,381,500 | |
| $25.82 | -0.22 | -0.8% | $26.35 | $26.92 | $25.39 | 1,736,100 | |
| $26.04 | +0.26 | +1.0% | $25.47 | $26.11 | $25.47 | 1,597,400 | |
| $25.78 | -0.43 | -1.6% | $26.00 | $26.23 | $25.17 | 1,244,200 | |
| $26.21 | -0.665 | -2.5% | $26.52 | $26.87 | $26.13 | 929,200 | |
| $26.88 | +0.165 | +0.6% | $26.80 | $27.50 | $26.24 | 1,256,800 | |
| $26.71 | -0.24 | -0.9% | $26.77 | $27.23 | $26.44 | 551,900 | |
| $26.95 | +0.68 | +2.6% | $26.72 | $27.38 | $26.38 | 1,176,300 | |
| $26.27 | -0.45 | -1.7% | $26.37 | $26.69 | $25.86 | 874,200 | |
| $26.72 | -0.33 | -1.2% | $27.41 | $27.50 | $26.70 | 1,485,900 | |
| $27.05 | -0.74 | -2.7% | $27.33 | $27.57 | $26.68 | 1,086,900 | |
| $27.79 | +0.86 | +3.2% | $27.50 | $28.23 | $27.02 | 2,102,000 | |
| $26.93 | -0.24 | -0.9% | $26.51 | $27.04 | $26.51 | 816,000 | |
| $27.17 | +0.12 | +0.4% | $26.62 | $27.22 | $26.50 | 1,152,800 | |
| $27.05 | -0.14 | -0.5% | $27.01 | $27.25 | $26.19 | 738,300 | |
| $27.19 | +0.56 | +2.1% | $26.92 | $27.35 | $26.44 | 1,371,900 | |
| $26.63 | +0.67 | +2.6% | $25.95 | $26.82 | $25.78 | 912,700 | |
| $25.96 | +0.08 | +0.3% | $26.03 | $26.36 | $25.46 | 700,400 | |
| $25.88 | +0.35 | +1.4% | $25.36 | $26.04 | $25.13 | 898,900 | |
| $25.53 | +0.31 | +1.2% | $25.27 | $25.89 | $25.00 | 729,500 | |
| $25.22 | +0.10 | +0.4% | $25.18 | $25.49 | $24.57 | 805,100 | |
| $25.12 | +0.43 | +1.7% | $24.92 | $25.40 | $24.54 | 1,344,000 | |
| $24.69 | +1.47 | +6.3% | $23.70 | $24.83 | $23.24 | 1,191,400 | |
| $23.22 | +0.01 | 0.0% | $22.96 | $23.31 | $22.64 | 1,351,800 | |
| $23.21 | -0.37 | -1.6% | $23.58 | $23.78 | $23.08 | 761,600 | |
| $23.58 | -0.02 | -0.1% | $23.90 | $23.90 | $22.91 | 1,248,800 |
- Ticker
- NASDAQ:NRIX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 12, 2026
Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Latest deck · Jun 14, 2026
EHA 2026 Annual Meeting
Conference · 15 slides
Latest news
Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Oct 12, 2026
Closed $22.13 (-0.1%) on Oct 13, 2026
Nurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia
Oct 6, 2026
Closed $22.60 (-1.2%) on Oct 6, 2026
Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences
Oct 5, 2026
Closed $22.88 (-0.5%) on Oct 5, 2026
Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer
Sep 29, 2026
Closed $23.68 (0.0%) on Sep 29, 2026
Nurix Therapeutics to Participate in Upcoming September Investor Conferences
Sep 1, 2026
Closed $26.04 (+1.0%) on Sep 1, 2026
Nurix Therapeutics Announces Appointment of Wes Burwell as Chief Human Resources Officer
Aug 20, 2026
Closed $27.05 (-2.7%) on Aug 20, 2026
Nurix Announces $10 Million Milestone Payment Associated with Initiation of a Phase 1 Clinical Trial of a STAT6 Degrader
Aug 4, 2026
Closed $24.69 (+6.3%) on Aug 4, 2026
Nurix Therapeutics Announces First Patient Enrolled in Registrational Phase 3 DAYBreak CLL-306 Trial of Bexobrutideg in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Aug 4, 2026
Closed $24.69 (+6.3%) on Aug 4, 2026
Nurix Therapeutics Announces HSR Clearance of Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology
Jul 21, 2026
Closed $23.60 (+0.5%) on Jul 22, 2026
Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Jul 9, 2026
Closed $23.06 (-6.6%) on Jul 10, 2026
Decks
EHA 2026 Annual Meeting
Conference · 15 slides · Jun 14, 2026
Merger or Acquisition (June 2026)
Merger or acquisition · 19 slides · Jun 8, 2026
Technical Presentation (April 2026)
Technical · 21 slides · April 2026
J.P. Morgan Healthcare Conference 2026
Conference · 27 slides · Jan 12, 2026
Nurix Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 28 in the last 12 months · 178 in all · newest Oct 12, 2026 · oldest 2020
- Decks
- 32 decks · latest Jun 14, 2026
Where Nurix Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NRIX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:NRIX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Nurix Therapeutics, Inc.